BOPO — Biopower Operations Balance Sheet
0.000.00%
FinancialsHighly SpeculativeMicro Cap
- $0.00m
- $2.63m
- $0.57m
Annual balance sheet for Biopower Operations, fiscal year end - November 30th, USD millions except per share, conversion factor applied.
2015 November 30th | 2019 November 30th | 2020 November 30th | 2021 November 30th | 2022 November 30th | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Short Term Investments | 0.001 | 0 | 0 | 0.096 | 0.001 |
Net Total Accounts Receivable | |||||
Net Total Receivables | — | — | — | — | 0 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Current Assets | 0.014 | 0 | 0 | 0.096 | 0.014 |
Net Property, Plant And Equipment | 0.011 | — | — | — | — |
Long Term Investments | |||||
Total Assets | 0.032 | 0 | 0 | 0.096 | 0.014 |
Payable / Accrued | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 3.91 | 4.23 | 4.36 | 5.51 | 5.95 |
Total Long Term Debt | |||||
Total Debt | |||||
Total Liabilities | 3.91 | 4.23 | 4.36 | 5.51 | 5.95 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | -3.87 | -4.23 | -4.36 | -5.41 | -5.94 |
Total Liabilities & Shareholders' Equity | 0.032 | 0 | 0 | 0.096 | 0.014 |
Total Common Shares Outstanding | |||||
Total Preferred Shares Outstanding |